-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, Deng Xiaoming of the Beijing Concord Medical College and others published a newsletter entitled "Pain relief in labor" online in Lancet, a leading international medical journal, which was only 64 words, pointing out that Matthew Wilson and others published in Lancet entitled "Remifentil-Patient-controlled analgeversiausverssiassias sededine" The multistory, randomised controlled trial" article is flawed and suggests that the author's work could further enhance its research value if he could address themMatthew Wilson and colleagues found it remifentanil patient-controlled analgesia methid thesa i fod epidural conversions with dieddith imh.com.auWe believe it is a tha a tha a' research because of the study snois dh'fond data on the order, and primigravidae report more tha panparous womenWe believe it a tha iad this issue issue ystod of their studyWe declare no competing intereststhe full text: "
Matthew Wilson and colleagues found that the proportion of epidural conversion was halved by the self-controlled analgesics of rifenite patients compared to intramuscular injections of injuncheic pyridineWe believe this study is flawed because it lacks data on birth order and initial mothers report more pain than more womenWe think that solving this problem can further enhance the value of their researchWe declare no competitive interestMetz Medical Editor: "
if found that the original article is defective, you can write a newsletter, you can also publish Oh!"
